PortView
VanEck Pharmaceutical (PPH) ETF Holdings & Analysis
ETFOther
What PPH does
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| Eli Lilly & Co | 18.89% | |
| Merck & Co Inc | 10.96% | |
| Novartis Ag | 9.98% | |
| Pfizer Inc | 5.16% | |
| Bristol-Myers Squibb Co | 5.02% | |
| Novo Nordisk A/S | 4.91% | |
| Mckesson Corp | 4.67% | |
| Abbvie Inc | 4.51% | |
| Johnson & Johnson | 4.41% | |
| Gsk Plc | 4.10% |
Sector allocation
| Healthcare | 100.00% |
Geographic allocation
| United States | 62.38% |
| United Kingdom | 10.88% |
| Switzerland | 10.08% |
| Denmark | 4.98% |
| France | 4.04% |
| Israel | 3.26% |
| Japan | 3.10% |
| Ireland | 1.16% |
| Canada | 0.12% |
| Other | — |
PortView Portfolio Insights
PortView analyzes how PPH fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze PPH in PortView →Related securities
Related stocks
Frequently asked questions
- What does PPH track?
- PPH is the VanEck Pharmaceutical ETF, a Other ETF.
- What is the expense ratio of PPH?
- Expense ratio data for PPH is shown on the page when available from our data provider.
- What are the largest holdings in PPH?
- Top holdings include LLY, MRK, NVS, PFE, BMY.
- How can PortView analyze PPH overlap with other ETFs?
- PortView computes the holdings overlap between PPH and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.